Acer Medical Inc. (TPEX:6857)

Acer Medical Statistics

Total Valuation

Acer Medical has a market cap or net worth of TWD 1.52 billion. The enterprise value is 1.34 billion.

Market Cap	1.52B
Enterprise Value	1.34B

Important Dates

The next estimated earnings date is Friday, April 17, 2026.

Earnings Date	Apr 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Acer Medical has 15.23 million shares outstanding.

Current Share Class	15.23M
Shares Outstanding	15.23M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.78%
Owned by Institutions (%)	0.54%
Float	3.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	27.63
PB Ratio	8.48
P/TBV Ratio	8.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-44.20
EV / Sales	24.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-55.84

Financial Position

The company has a current ratio of 6.76

Current Ratio	6.76
Quick Ratio	6.54
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -15.58% and return on invested capital (ROIC) is -10.64%.

Return on Equity (ROE)	-15.58%
Return on Assets (ROA)	-9.13%
Return on Invested Capital (ROIC)	-10.64%
Return on Capital Employed (ROCE)	-18.46%
Weighted Average Cost of Capital (WACC)	9.59%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.24
Inventory Turnover	3.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.26% in the last 52 weeks. The beta is 0.97, so Acer Medical's price volatility has been similar to the market average.

Beta (5Y)	0.97
52-Week Price Change	-21.26%
50-Day Moving Average	107.01
200-Day Moving Average	122.21
Relative Strength Index (RSI)	39.16
Average Volume (20 Days)	1,562

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Acer Medical had revenue of TWD 55.10 million and -30.32 million in losses. Loss per share was -1.99.

Revenue	55.10M
Gross Profit	32.85M
Operating Income	-33.12M
Pretax Income	-30.32M
Net Income	-30.32M
EBITDA	-32.59M
EBIT	-33.12M
Loss Per Share	-1.99

Balance Sheet

The company has 182.27 million in cash and n/a in debt, with a net cash position of 182.27 million or 11.97 per share.

Cash & Cash Equivalents	182.27M
Total Debt	n/a
Net Cash	182.27M
Net Cash Per Share	11.97
Equity (Book Value)	179.45M
Book Value Per Share	11.79
Working Capital	172.94M

Cash Flow

In the last 12 months, operating cash flow was -23.62 million and capital expenditures -386,000, giving a free cash flow of -24.01 million.

Operating Cash Flow	-23.62M
Capital Expenditures	-386,000
Free Cash Flow	-24.01M
FCF Per Share	-1.58

Margins

Gross margin is 59.62%, with operating and profit margins of -60.11% and -55.03%.

Gross Margin	59.62%
Operating Margin	-60.11%
Pretax Margin	-55.03%
Profit Margin	-55.03%
EBITDA Margin	-59.15%
EBIT Margin	-60.11%
FCF Margin	n/a

Dividends & Yields

Acer Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1.99%
FCF Yield	-1.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Acer Medical has an Altman Z-Score of 43.47 and a Piotroski F-Score of 2.

Altman Z-Score	43.47
Piotroski F-Score	2